Natalizumab in multiple sclerosis: discontinuation, progressive multifocal leukoencephalopathy and possible use in children. Vitaliti G, Matin N, Tabatabaie O, Di Traglia M, Pavone P, Lubrano R, Falsaperla R Expert Rev Neurother. 2015 Oct 29:1-21. PMID: 26513633. Abstract CommentRecommendBookmarkWatch